Analyst Consensus Rating

Investment consensus from 14 professional research analysts

Consensus Rating

Buy
Based on 14 unique analysts
(18 total ratings in last 90 days)
High Confidence:1 Buy/Sell

Average Price Target

$142.50
8.22% Downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest GILD Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Gregory Renza
Truist
Strong BuyMaintains
$140.00 $145.00
Geoff Meacham
Citi
Strong BuyMaintains
$140.00 $156.00
Michael Yee
UBS
Strong BuyMaintains
$145.00 $155.00
Matthew Harrison
Morgan Stanley
BuyMaintains
$151.00 $150.00
Michael Yee
UBS
Strong BuyInitiates
$112.00 $145.00
Geoff Meacham
Citi
Strong BuyMaintains
$135.00 $140.00
Joseph Stringer
Needham
BuyMaintains
$140.00
Matthew Harrison
Morgan Stanley
BuyMaintains
$147.00 $151.00
Morten Herholdt
HSBC
HoldMaintains
$110.00 $133.00
Mohit Bansal
Wells Fargo
BuyMaintains
$145.00 $150.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$137.00 $141.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
BuyReiterates
$135.00 $136.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
BuyReiterates
$137.00 $139.00
xAi Drug Manufacturers - General
TipRanks - xAI
BuyReiterates
$135.00 $137.00
OpenAI Drug Manufacturers - General
TipRanks - OpenAI
BuyReiterates
$136.00 $138.00
Carter Gould
Cantor Fitzgerald
BuyMaintains
$135.00
Gregory Renza
Truist
Strong BuyInitiates
$145.00 $140.00
Salim Syed
Mizuho
BuyMaintains
$131.00 $140.00